Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax Announces Positive Top-Line Data From RSV F Vaccine Phase 1 Clinical Trial in Pediatrics
- RSV
Sep 29, 2015
Novavax to Present at the Ladenburg Thalmann 2015 Healthcare Conference
- Corporate and Finance
Sep 21, 2015
Novavax RSV F Vaccine is Highly Immunogenic With Robust Transplacental Antibody Transfer in Preclinical Maternal Immunization Model
- RSV
Sep 15, 2015
Novavax RSV F Vaccine Clinical Trial Data in Women of Child Bearing Age Published in the Journal of Infectious Disease
- RSV
Sep 10, 2015
Novavax to Participate in Multiple Investor Conferences in September
- Corporate and Finance
Sep 2, 2015
Novavax to Host 3rd Annual Analyst and Investor Meeting
- Corporate and Finance
Aug 26, 2015
Novavax Reports Second Quarter 2015 Financial Results
- Corporate and Finance
Aug 10, 2015
Novavax Announces Positive Top-Line Data from Phase 2 RSV F-Protein Vaccine Clinical Trial in Older Adults
- RSV
Aug 10, 2015
Novavax to Present at the Wedbush PacGrow Healthcare Conference
- Corporate and Finance
Aug 5, 2015
Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 10, 2015
- Corporate and Finance
Aug 3, 2015

Show per page